mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
Heng-Jia Liu (),
Heng Du,
Damir Khabibullin,
Mahsa Zarei,
Kevin Wei,
Gordon J. Freeman,
David J. Kwiatkowski and
Elizabeth P. Henske ()
Additional contact information
Heng-Jia Liu: Brigham and Women’s Hospital and Harvard Medical School
Heng Du: Brigham and Women’s Hospital and Harvard Medical School
Damir Khabibullin: Brigham and Women’s Hospital and Harvard Medical School
Mahsa Zarei: Brigham and Women’s Hospital and Harvard Medical School
Kevin Wei: Brigham and Women’s Hospital and Harvard Medical School
Gordon J. Freeman: Harvard Medical School
David J. Kwiatkowski: Brigham and Women’s Hospital and Harvard Medical School
Elizabeth P. Henske: Brigham and Women’s Hospital and Harvard Medical School
Nature Communications, 2023, vol. 14, issue 1, 1-22
Abstract:
Abstract Identifying the mechanisms underlying the regulation of immune checkpoint molecules and the therapeutic impact of targeting them in cancer is critical. Here we show that high expression of the immune checkpoint B7-H3 (CD276) and high mTORC1 activity correlate with immunosuppressive phenotypes and worse clinical outcomes in 11,060 TCGA human tumors. We find that mTORC1 upregulates B7-H3 expression via direct phosphorylation of the transcription factor YY2 by p70 S6 kinase. Inhibition of B7-H3 suppresses mTORC1-hyperactive tumor growth via an immune-mediated mechanism involving increased T-cell activity and IFN-γ responses coupled with increased tumor cell expression of MHC-II. CITE-seq reveals strikingly increased cytotoxic CD38+CD39+CD4+ T cells in B7-H3-deficient tumors. In pan-human cancers, a high cytotoxic CD38+CD39+CD4+ T-cell gene signature correlates with better clinical prognosis. These results show that mTORC1-hyperactivity, present in many human tumors including tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM), drives B7-H3 expression leading to suppression of cytotoxic CD4+ T cells.
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-023-36881-7 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36881-7
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-023-36881-7
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().